{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T07:28:54Z","timestamp":1790234934684,"version":"4.1.0"},"reference-count":83,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","heartlungcirc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heart, Lung and Circulation"],"published-print":{"date-parts":[[2023,5]]},"DOI":"10.1016\/j.hlc.2023.02.004","type":"journal-article","created":{"date-parts":[[2023,3,14]],"date-time":"2023-03-14T16:39:50Z","timestamp":1678811990000},"page":"587-595","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["A Narrative Review\u2014Management of Malignant Pleural Effusion Related to Malignant Pleural Mesothelioma"],"prefix":"10.1016","volume":"32","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0925-4931","authenticated-orcid":false,"given":"Maryum","family":"Qureshi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bibhusal","family":"Thapa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanjeevan","family":"Muruganandan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.hlc.2023.02.004_bib1","doi-asserted-by":"crossref","first-page":"535","DOI":"10.2486\/indhealth.46.535","article-title":"Asbestos-related occupational lung diseases in NSW, Australia and potential exposureof the general population","volume":"46","author":"Park","year":"2008","journal-title":"Ind Health"},{"key":"10.1016\/j.hlc.2023.02.004_bib2","year":"2020","journal-title":"Mesothelioma in Australia"},{"issue":"2","key":"10.1016\/j.hlc.2023.02.004_bib3","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1007\/s13665-019-0224-9","article-title":"Malignant pleural mesothelioma: an update for pulmonologists","volume":"8","author":"Sidhu","year":"2019","journal-title":"Curr Pulmonol Rep"},{"issue":"4","key":"10.1016\/j.hlc.2023.02.004_bib4","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1097\/MCP.0000000000000685","article-title":"Management of malignant pleural effusions","volume":"26","author":"Dipper","year":"2020","journal-title":"Curr Opin Pulm Med"},{"issue":"142","key":"10.1016\/j.hlc.2023.02.004_bib5","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1183\/16000617.0063-2016","article-title":"Malignant pleural mesothelioma: an update on investigation, diagnosis and treatment","volume":"25","author":"Bibby","year":"2016","journal-title":"Eur Respir Rev"},{"issue":"1","key":"10.1016\/j.hlc.2023.02.004_bib6","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1097\/CCO.0000000000000697","article-title":"Malignant pleural mesothelioma: recent developments","volume":"33","author":"Sinn","year":"2021","journal-title":"Curr Opin Oncol"},{"issue":"3","key":"10.1016\/j.hlc.2023.02.004_bib7","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1038\/sj.bjc.6602307","article-title":"The expected burden of mesothelioma mortality in Great Britain from 2002 to 2050","volume":"92","author":"Hodgson","year":"2005","journal-title":"Br J Cancer"},{"key":"10.1016\/j.hlc.2023.02.004_bib8","series-title":"Occupational disorders of the lung: recognition, management and prevention","author":"Hendrick","year":"2002"},{"issue":"4","key":"10.1016\/j.hlc.2023.02.004_bib9","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1289\/ehp.1002845","article-title":"Global magnitude of reported and unreported mesothelioma","volume":"119","author":"Park","year":"2011","journal-title":"Environ Health Perspect"},{"issue":"4","key":"10.1016\/j.hlc.2023.02.004_bib10","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.jtho.2015.12.108","article-title":"A\u00a0novel clinical prediction model for prognosis in malignant pleural mesothelioma using decision tree analysis","volume":"11","author":"Brims","year":"2016","journal-title":"J\u00a0Thorac Oncol"},{"issue":"6","key":"10.1016\/j.hlc.2023.02.004_bib11","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1183\/09031936.00000811","article-title":"Predicting survival in malignant mesothelioma","volume":"38","author":"Musk","year":"2011","journal-title":"Eur Respir J"},{"issue":"6","key":"10.1016\/j.hlc.2023.02.004_bib12","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1038\/bjc.2017.20","article-title":"Comparison of outcomes following a cytological or histological diagnosis of malignant mesothelioma","volume":"116","author":"Muruganandan","year":"2017","journal-title":"Br J Cancer"},{"issue":"2","key":"10.1016\/j.hlc.2023.02.004_bib13","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.jtho.2015.10.003","article-title":"Contemporary analysis of prognostic factors in patients with unresectable malignant pleural mesothelioma","volume":"11","author":"Bille","year":"2016","journal-title":"J\u00a0Thorac Oncol"},{"issue":"1","key":"10.1016\/j.hlc.2023.02.004_bib14","volume":"6","author":"Matthews","year":"2019","journal-title":"BMJ Open Respir Res"},{"issue":"1","key":"10.1016\/j.hlc.2023.02.004_bib15","doi-asserted-by":"crossref","first-page":"205","DOI":"10.2147\/TCRM.S1603","article-title":"Review of pemetrexed in combination with cisplatin for the treatment of malignant pleural mesothelioma","volume":"4","author":"Goudar","year":"2008","journal-title":"Ther Clin Risk manag"},{"issue":"14","key":"10.1016\/j.hlc.2023.02.004_bib16","doi-asserted-by":"crossref","first-page":"2636","DOI":"10.1200\/JCO.2003.11.136","article-title":"Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma","volume":"21","author":"Vogelzang","year":"2003","journal-title":"J\u00a0Clin Oncol"},{"issue":"10272","key":"10.1016\/j.hlc.2023.02.004_bib17","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/S0140-6736(20)32714-8","article-title":"First-line nivolumab plus ipilimumab in unresectable malignant pleural mesothelioma (CheckMate 743): a multicentre, randomised, open-label, phase 3 trial","volume":"30","author":"Baas","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.hlc.2023.02.004_bib18","doi-asserted-by":"crossref","first-page":"187","DOI":"10.3389\/fonc.2020.00187","article-title":"Immunotherapy in malignant pleural mesothelioma","volume":"10","author":"de Gooijer","year":"2020","journal-title":"Front Oncol"},{"issue":"18","key":"10.1016\/j.hlc.2023.02.004_bib19","article-title":"Management of pleural effusion secondary to malignant mesothelioma","volume":"10","author":"Musso","year":"2021","journal-title":"J\u00a0Clin Med"},{"key":"10.1016\/j.hlc.2023.02.004_bib20","series-title":"Occupational disorders of the lung: recognition, management and prevention","author":"Hendrick","year":"2002"},{"key":"10.1016\/j.hlc.2023.02.004_bib21","doi-asserted-by":"crossref","first-page":"20","DOI":"10.21037\/amj.2020.02.09","article-title":"Possibilities of surgical pleurodesis for malignant pleural effusion","volume":"5","author":"Ricciardi","year":"2020","journal-title":"AME Med J"},{"issue":"7","key":"10.1016\/j.hlc.2023.02.004_bib22","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1164\/rccm.201807-1415ST","article-title":"Management of malignant pleural effusions. An official ATS\/STS\/STR clinical practice guideline","volume":"198","author":"Feller-Kopman","year":"2018","journal-title":"Am J Respir Crit Care Med"},{"issue":"Suppl 2","key":"10.1016\/j.hlc.2023.02.004_bib23","doi-asserted-by":"crossref","first-page":"ii32","DOI":"10.1136\/thx.2010.136994","article-title":"Group BTSPDG. Management of a malignant pleural effusion: British Thoracic Society Pleural Disease Guideline 2010","volume":"65","author":"Roberts","year":"2010","journal-title":"Thorax"},{"issue":"12","key":"10.1016\/j.hlc.2023.02.004_bib24","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1136\/thoraxjnl-2014-205285","article-title":"Predicting survival in malignant pleural effusion: development and validation of the LENT prognostic score","volume":"69","author":"Clive","year":"2014","journal-title":"Thorax"},{"issue":"7","key":"10.1016\/j.hlc.2023.02.004_bib25","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1016\/S1470-2045(18)30294-8","article-title":"Development and validation of response markers to predict survival and pleurodesis success in patients with malignant pleural effusion (PROMISE): a multicohort analysis","volume":"19","author":"Psallidas","year":"2018","journal-title":"Lancet Oncol"},{"issue":"1","key":"10.1016\/j.hlc.2023.02.004_bib26","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.chest.2021.02.052","article-title":"Breathlessness predicts survival in patients with malignant pleural effusions: meta-analysis of individual patient data from five randomized controlled trials","volume":"160","author":"Mishra","year":"2021","journal-title":"Chest"},{"issue":"5","key":"10.1016\/j.hlc.2023.02.004_bib27","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1016\/j.chest.2021.05.063","article-title":"The association between pleural fluid exposure and survival in pleural mesothelioma","volume":"160","author":"Asciak","year":"2021","journal-title":"Chest"},{"issue":"3","key":"10.1016\/j.hlc.2023.02.004_bib28","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1111\/j.1752-699X.2011.00254.x","article-title":"Outcomes and complications following medical thoracoscopy","volume":"6","author":"Brims","year":"2012","journal-title":"Clin Respir J"},{"issue":"2","key":"10.1016\/j.hlc.2023.02.004_bib29","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1159\/000335419","article-title":"Mechanisms of pleurodesis","volume":"83","author":"Rodriguez-Panadero","year":"2012","journal-title":"Respiration"},{"issue":"Suppl 2","key":"10.1016\/j.hlc.2023.02.004_bib30","first-page":"ii1","article-title":"BTS statement on malignant mesothelioma in the UK, 2007","volume":"62","year":"2007","journal-title":"Thorax"},{"issue":"5","key":"10.1016\/j.hlc.2023.02.004_bib31","first-page":"CD010529","article-title":"Interventions for the management of malignant pleural effusions: a network meta-analysis","author":"Clive","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"issue":"10","key":"10.1016\/j.hlc.2023.02.004_bib32","doi-asserted-by":"crossref","first-page":"2463","DOI":"10.1111\/crj.12958","article-title":"Recent developments in pleurodesis for malignant pleural disease","volume":"12","author":"Guinde","year":"2018","journal-title":"Clin Respir J"},{"issue":"6","key":"10.1016\/j.hlc.2023.02.004_bib33","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1136\/thoraxjnl-2012-203043","article-title":"Pleurodesis outcome in malignant pleural mesothelioma","volume":"68","author":"Fysh","year":"2013","journal-title":"Thorax"},{"issue":"1","key":"10.1016\/j.hlc.2023.02.004_bib34","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1001\/jama.2019.19997","article-title":"Effect of thoracoscopic talc poudrage vs talc slurry via chest tube on pleurodesis failure rate among patients with malignant pleural effusions: a randomized clinical trial","volume":"323","author":"Bhatnagar","year":"2020","journal-title":"JAMA"},{"issue":"22","key":"10.1016\/j.hlc.2023.02.004_bib35","doi-asserted-by":"crossref","first-page":"2383","DOI":"10.1001\/jama.2012.5535","article-title":"Effect of an indwelling pleural catheter vs chest tube and talc pleurodesis for relieving dyspnea in patients with malignant pleural effusion: the TIME2 randomized controlled trial","volume":"307","author":"Davies","year":"2012","journal-title":"JAMA"},{"issue":"10","key":"10.1016\/j.hlc.2023.02.004_bib36","doi-asserted-by":"crossref","first-page":"1992","DOI":"10.1002\/(SICI)1097-0142(19991115)86:10<1992::AID-CNCR16>3.0.CO;2-M","article-title":"A\u00a0randomized comparison of indwelling pleural catheter and doxycycline pleurodesis in the management of malignant pleural effusions","volume":"86","author":"Putnam","year":"1999","journal-title":"Cancer"},{"issue":"19","key":"10.1016\/j.hlc.2023.02.004_bib37","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1001\/jama.2017.17426","article-title":"Effect of an indwelling pleural catheter vs talc pleurodesis on hospitalization days in patients with malignant pleural effusion: the AMPLE randomized clinical trial","volume":"318","author":"Thomas","year":"2017","journal-title":"JAMA"},{"issue":"24","key":"10.1016\/j.hlc.2023.02.004_bib38","doi-asserted-by":"crossref","first-page":"2641","DOI":"10.1001\/jama.2015.16840","article-title":"Effect of opioids vs NSAIDs and larger vs smaller chest tube size on pain control and pleurodesis efficacy among patients with malignant pleural effusion: The TIME1 Randomized Clinical Trial","volume":"314","author":"Rahman","year":"2015","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.hlc.2023.02.004_bib39","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1378\/chest.127.3.909","article-title":"Phase III intergroup study of talc poudrage vs talc slurry sclerosis for malignant pleural effusion","volume":"127","author":"Dresler","year":"2005","journal-title":"Chest"},{"issue":"11","key":"10.1016\/j.hlc.2023.02.004_bib40","first-page":"3109","article-title":"Comparison of modified Borg scale and visual analog scale dyspnea scores in predicting re-intervention after drainage of malignant pleural effusion","volume":"21","author":"Boshuizen","year":"2013","journal-title":"Support Care Cancer"},{"issue":"5","key":"10.1016\/j.hlc.2023.02.004_bib41","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1164\/ajrccm.153.5.8630595","article-title":"Does oxygen help dyspnea\u00a0in patients with cancer?","volume":"153","author":"Booth","year":"1996","journal-title":"Am J Respir Crit Care Med"},{"issue":"5 Suppl","key":"10.1016\/j.hlc.2023.02.004_bib42","doi-asserted-by":"crossref","first-page":"e455S","DOI":"10.1378\/chest.12-2366","article-title":"Symptom management in patients with lung cancer: diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines","volume":"143","author":"Simoff","year":"2013","journal-title":"Chest"},{"key":"10.1016\/j.hlc.2023.02.004_bib43","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.lungcan.2017.01.019","article-title":"A\u00a0randomized controlled trial comparing indwelling pleural catheters with talc pleurodesis (NVALT-14)","volume":"108","author":"Boshuizen","year":"2017","journal-title":"Lung Cancer"},{"issue":"2","key":"10.1016\/j.hlc.2023.02.004_bib44","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1378\/chest.11-2657","article-title":"Indwelling pleural catheters reduce inpatient days over pleurodesis for malignant pleural effusion","volume":"142","author":"Fysh","year":"2012","journal-title":"Chest"},{"issue":"9","key":"10.1016\/j.hlc.2023.02.004_bib45","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/S2213-2600(18)30288-1","article-title":"Aggressive versus symptom-guided drainage of malignant pleural effusion via indwelling pleural catheters (AMPLE-2): an open-label randomised trial","volume":"6","author":"Muruganandan","year":"2018","journal-title":"Lancet Respir Med"},{"issue":"8","key":"10.1016\/j.hlc.2023.02.004_bib46","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1164\/rccm.201607-1404OC","article-title":"Randomized trial of pleural fluid drainage frequency in patients with malignant pleural effusions. The ASAP Trial","volume":"195","author":"Wahidi","year":"2017","journal-title":"Am J Respir Crit Care Med"},{"issue":"3","key":"10.1016\/j.hlc.2023.02.004_bib47","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1016\/j.athoracsur.2007.11.039","article-title":"Management of malignant pleural effusions using the Pleur(x) catheter","volume":"85","author":"Warren","year":"2008","journal-title":"Ann Thorac Surg"},{"issue":"3","key":"10.1016\/j.hlc.2023.02.004_bib48","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1097\/LBR.0000000000000192","article-title":"Management of malignant pleural effusion","volume":"22","author":"Shafiq","year":"2015","journal-title":"J\u00a0bronchology Interv Pulmonol"},{"issue":"1","key":"10.1016\/j.hlc.2023.02.004_bib49","article-title":"Complications of indwelling pleural catheter use and their management","volume":"3","author":"Lui","year":"2016","journal-title":"BMJ Open Respir Res"},{"issue":"5","key":"10.1016\/j.hlc.2023.02.004_bib50","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1378\/chest.12-3103","article-title":"Clinical outcomes of indwelling pleural catheter-related pleural infections: an international multicenter study","volume":"144","author":"Fysh","year":"2013","journal-title":"Chest"},{"issue":"5","key":"10.1016\/j.hlc.2023.02.004_bib51","doi-asserted-by":"crossref","first-page":"2221","DOI":"10.1016\/j.chest.2020.05.594","article-title":"Management of indwelling tunneled pleural catheters: a modified delphi consensus statement","volume":"158","author":"Gilbert","year":"2020","journal-title":"Chest"},{"issue":"4","key":"10.1016\/j.hlc.2023.02.004_bib52","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1097\/LBR.0000000000000001","article-title":"Infections associated with tunnelled indwelling pleural catheters in patients undergoing chemotherapy","volume":"20","author":"Mekhaiel","year":"2013","journal-title":"J\u00a0Bronchology Interv Pulmonol"},{"issue":"6","key":"10.1016\/j.hlc.2023.02.004_bib53","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1016\/j.chest.2016.01.001","article-title":"Longitudinal measurement of pleural fluid biochemistry and cytokines in malignant pleural effusions","volume":"149","author":"Thomas","year":"2016","journal-title":"Chest"},{"issue":"1","key":"10.1016\/j.hlc.2023.02.004_bib54","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1007\/s11606-010-1472-0","article-title":"Efficacy and safety of tunneled pleural catheters in adults with malignant pleural effusions: a systematic review","volume":"26","author":"Van Meter","year":"2011","journal-title":"J\u00a0Gen Intern Med"},{"issue":"4","key":"10.1016\/j.hlc.2023.02.004_bib55","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1097\/MCP.0b013e32833a233b","article-title":"Risk reduction in pleural procedures: sonography, simulation and supervision","volume":"16","author":"Wrightson","year":"2010","journal-title":"Curr Opin Pulm Med"},{"issue":"3","key":"10.1016\/j.hlc.2023.02.004_bib56","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1378\/chest.13-3057","article-title":"Catheter tract metastasis associated with indwelling pleural catheters","volume":"146","author":"Thomas","year":"2014","journal-title":"Chest"},{"issue":"4","key":"10.1016\/j.hlc.2023.02.004_bib57","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1378\/chest.06-2353","article-title":"Catheter-tract metastases associated with chronic indwelling pleural catheters","volume":"131","author":"Janes","year":"2007","journal-title":"Chest"},{"issue":"2","key":"10.1016\/j.hlc.2023.02.004_bib58","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.lungcan.2009.06.014","article-title":"Prophylactic radiotherapy to intervention sites in mesothelioma: a systematic review and survey of UK practice","volume":"66","author":"Lee","year":"2009","journal-title":"Lung Cancer"},{"issue":"8","key":"10.1016\/j.hlc.2023.02.004_bib59","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1016\/S1470-2045(16)30095-X","article-title":"Prophylactic radiotherapy for the prevention of procedure-tract metastases after surgical and large-bore pleural procedures in malignant pleural mesothelioma (SMART): a multicentre, open-label,\u00a0phase 3, randomised controlled trial","volume":"17","author":"Clive","year":"2016","journal-title":"Lancet Oncol"},{"issue":"14","key":"10.1016\/j.hlc.2023.02.004_bib60","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1056\/NEJMoa1716883","article-title":"Outpatient talc administration by indwelling pleural catheter for malignant effusion","volume":"378","author":"Bhatnagar","year":"2018","journal-title":"N\u00a0Engl J Med"},{"issue":"1","key":"10.1016\/j.hlc.2023.02.004_bib61","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1164\/rccm.201701-0097LE","article-title":"A\u00a0novel drug-eluting indwelling pleural catheter for the management of malignant effusions","volume":"197","author":"Bhatnagar","year":"2018","journal-title":"Am J Respir Crit Care Med"},{"issue":"10","key":"10.1016\/j.hlc.2023.02.004_bib62","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1513\/AnnalsATS.202111-1301OC","article-title":"Silver nitrate-coated versus standard indwelling pleural catheter for malignant effusions: the SWIFT randomized trial","volume":"19","author":"Shrager","year":"2022","journal-title":"Ann Am Thor Soc"},{"issue":"2","key":"10.1016\/j.hlc.2023.02.004_bib63","first-page":"106","article-title":"Management of malignant pleural effusions with indwelling pleural catheters or talc pleurodesis","volume":"20","author":"Srour","year":"2013","journal-title":"Can Resp J"},{"issue":"8","key":"10.1016\/j.hlc.2023.02.004_bib64","doi-asserted-by":"crossref","first-page":"975","DOI":"10.6004\/jnccn.2012.0102","article-title":"Optimal management of malignant pleural effusions (results of CALGB 30102)","volume":"10","author":"Demmy","year":"2012","journal-title":"J\u00a0Natl Compr Canc Netw"},{"issue":"19","key":"10.1016\/j.hlc.2023.02.004_bib65","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1001\/jama.2017.17426","article-title":"Effect of an indwelling pleural catheter vs talc pleurodesis on hospitalization days in patients with malignant pleural effusion: the AMPLE randomized clinical trial","volume":"318","author":"Thomas","year":"2017","journal-title":"JAMA"},{"issue":"13","key":"10.1016\/j.hlc.2023.02.004_bib66","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1200\/JCO.2017.76.6394","article-title":"Treatment of malignant pleural mesothelioma: American Society of Clinical Oncology Clinical Practice Guideline","volume":"36","author":"Kindler","year":"2018","journal-title":"J\u00a0Clin Oncol"},{"issue":"3","key":"10.1016\/j.hlc.2023.02.004_bib67","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1097\/JTO.0000000000000064","article-title":"Does surgery improve survival of patients with malignant pleural mesothelioma? A multicenter retrospective analysis of 1365 consecutive patients","volume":"9","author":"Bovolato","year":"2014","journal-title":"J\u00a0Thorac Oncol"},{"issue":"5","key":"10.1016\/j.hlc.2023.02.004_bib68","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/j.ejcts.2005.12.025","article-title":"The evidence on the effectiveness of management for malignant pleural effusion: a systematic review","volume":"29","author":"Tan","year":"2006","journal-title":"Eur J Cardiothorac Surg"},{"key":"10.1016\/j.hlc.2023.02.004_bib69","doi-asserted-by":"crossref","first-page":"254","DOI":"10.12688\/f1000research.5538.1","article-title":"Malignant pleural effusions and the role of talc poudrage and talc slurry: a systematic review and meta-analysis","volume":"3","author":"Mummadi","year":"2014","journal-title":"F1000Res"},{"issue":"1","key":"10.1016\/j.hlc.2023.02.004_bib70","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.thorsurg.2012.10.007","article-title":"Pleurectomy decortication in the treatment of the \u201ctrapped lung\u201d in benign and malignant pleural effusions","volume":"23","author":"Rathinam","year":"2013","journal-title":"Thorac Surg Clin"},{"issue":"1","key":"10.1016\/j.hlc.2023.02.004_bib71","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.ejcts.2007.09.039","article-title":"The role of video assisted thoracoscopic pleurectomy\/decortication in the therapeutic management of malignant pleural mesothelioma","volume":"33","author":"Nakas","year":"2008","journal-title":"Eur J Cardiothorac Surg"},{"issue":"3","key":"10.1016\/j.hlc.2023.02.004_bib72","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.ejso.2004.08.014","article-title":"Improved survival with VATS pleurectomy-decortication in advanced malignant mesothelioma","volume":"31","author":"Halstead","year":"2005","journal-title":"Eur J Surg Oncol"},{"issue":"3","key":"10.1016\/j.hlc.2023.02.004_bib73","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.acra.2010.10.009","article-title":"Quantitative measurement of lung reexpansion in malignant pleural mesothelioma patients undergoing pleurectomy\/decortication","volume":"18","author":"Sensakovic","year":"2011","journal-title":"Acad Radiol"},{"issue":"245","key":"10.1016\/j.hlc.2023.02.004_bib74","doi-asserted-by":"crossref","first-page":"15","DOI":"10.2217\/fon.15.274","article-title":"The MesoVATS trial: is there a future for video-assisted thoracoscopic surgery partial pleurectomy?","volume":"11","author":"Rintoul","year":"2015","journal-title":"Future Oncol"},{"issue":"6","key":"10.1016\/j.hlc.2023.02.004_bib75","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1510\/icvts.2009.211516","article-title":"Malignant pleural effusion in the presence of trapped lung. Five-year experience of PleurX tunnelled catheters","volume":"9","author":"Efthymiou","year":"2009","journal-title":"Interact Cardiovasc Thorac Surg"},{"issue":"3","key":"10.1016\/j.hlc.2023.02.004_bib76","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1111\/resp.13681","article-title":"Inter-observer variation in image interpretation and the prognostic importance of non-expansile lung in malignant pleural effusion","volume":"25","author":"Martin","year":"2020","journal-title":"Respirology"},{"issue":"4","key":"10.1016\/j.hlc.2023.02.004_bib77","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.21037\/jtd.2020.02.25","article-title":"Manometry performed at indwelling pleural catheter insertion to predict unexpandable lung","volume":"12","author":"Halford","year":"2020","journal-title":"J\u00a0Thorac Dis"},{"issue":"5","key":"10.1016\/j.hlc.2023.02.004_bib78","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1378\/chest.13-2876","article-title":"Novel use of pleural ultrasound can identify malignant entrapped lung prior to effusion drainage","volume":"146","author":"Salamonsen","year":"2014","journal-title":"Chest"},{"issue":"5","key":"10.1016\/j.hlc.2023.02.004_bib79","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/S2213-2600(18)30421-1","article-title":"Clinical utility of routine pleural manometry during therapeutic thoracentesis: a randomized trial","volume":"7","author":"Lentz","year":"2019","journal-title":"Lancet Respir Med"},{"issue":"2","key":"10.1016\/j.hlc.2023.02.004_bib80","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1378\/chest.11-2657","article-title":"Indwelling pleural catheters reduce inpatient days over pleurodesis for malignant pleural effusion","volume":"142","author":"Fysh","year":"2012","journal-title":"Chest"},{"issue":"5","key":"10.1016\/j.hlc.2023.02.004_bib81","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00980-2019","article-title":"The Pleural Effusion And Symptom Evaluation (PLEASE) study of breathlessness in patients with a symptomatic pleural effusion","volume":"55","author":"Muruganandan","year":"2020","journal-title":"Eur Respir J"},{"issue":"1","key":"10.1016\/j.hlc.2023.02.004_bib82","doi-asserted-by":"crossref","first-page":"1800349","DOI":"10.1183\/13993003.00349-2018","article-title":"ERS\/EACTS statement on the management of malignant pleural effusions","volume":"52","author":"Bibby","year":"2018","journal-title":"Eur Respir J"},{"issue":"6","key":"10.1016\/j.hlc.2023.02.004_bib83","doi-asserted-by":"crossref","first-page":"1900953","DOI":"10.1183\/13993003.00953-2019","article-title":"ERS\/ESTS\/EACTS\/ESTRO guidelines for the management of malignant pleural mesothelioma","volume":"55","author":"Scherpereel","year":"2020","journal-title":"Eur Respir J"}],"container-title":["Heart, Lung and Circulation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1443950623000999?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1443950623000999?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,25]],"date-time":"2025-10-25T18:07:18Z","timestamp":1761415638000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1443950623000999"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5]]},"references-count":83,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023,5]]}},"alternative-id":["S1443950623000999"],"URL":"https:\/\/doi.org\/10.1016\/j.hlc.2023.02.004","relation":{},"ISSN":["1443-9506"],"issn-type":[{"value":"1443-9506","type":"print"}],"subject":[],"published":{"date-parts":[[2023,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A Narrative Review\u2014Management of Malignant Pleural Effusion Related to Malignant Pleural Mesothelioma","name":"articletitle","label":"Article Title"},{"value":"Heart, Lung and Circulation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.hlc.2023.02.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Australian and New Zealand Society of Cardiac and Thoracic Surgeons (ANZSCTS) and the Cardiac Society of Australia and New Zealand (CSANZ). Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}